
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are a class of medications that reduce inflammation, relieve pain, and lower fever by inhibiting cyclooxygenase (COX) enzymes, which play a key role in the production of prostaglandins that mediate inflammation and pain. NSAIDs are widely used in the treatment of conditions such as arthritis, muscle pain, headaches, and menstrual cramps. They are also important in research focused on inflammatory processes, pain management, and the development of safer and more effective anti-inflammatory therapies. At CymitQuimica, we offer a variety of NSAIDs to support your research in pharmacology, inflammation, and pain management.
Found 450 products of "Nonsteroidal Anti-inflammatory Drugs (NSAIDs) "
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(1RS)-5-Benzoyl-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-2,3-dihydro-1H-pyrrolizine-1-carboxamide
CAS:Color and Shape:White2-Methoxynaphthalene(Nerolin)
CAS:Controlled ProductFormula:C11H10OColor and Shape:White To Off-WhiteMolecular weight:158.20Naproxen 1,3-Butylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Controlled ProductFormula:C18H22O4Color and Shape:MixtureMolecular weight:604.73Benzyl [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (Benzyl Ester of Aceclofenac)
CAS:Color and Shape:NeatAceclofenac 1,2-Propylene Glycol Esters (Mixture of Isomers)
Formula:C19H19Cl2NO5Color and Shape:NeatFenoprofen 1,3-Butylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C19H22O4Color and Shape:Neat[1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic Acid (3,4-Dichloroindometacin)
CAS:Color and Shape:NeatSulindac Amide ((Z)-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetamide)
Formula:C20H18FNO2SColor and Shape:NeatFlurbiprofen 1,2-Propylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C18H19FO3Color and Shape:NeatC-DIM 12
CAS:Formula:C23H17ClN2Purity:>98.0%(HPLC)(qNMR)Color and Shape:Orange to Amber to Dark red powder to crystalineMolecular weight:356.85Tiaprofenic Acid Ethyl Ester
CAS:Controlled ProductFormula:C16H16O3SColor and Shape:NeatMolecular weight:288.36Bardoxolone Methyl
CAS:Formula:C32H43NO4Purity:>95.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:505.70Dexibuprofen Ethyl Ester
CAS:Controlled ProductFormula:C15H22O2Color and Shape:NeatMolecular weight:234.33Naproxen EP Impurity B
CAS:Controlled ProductFormula:C14H13ClO3Color and Shape:NeatMolecular weight:264.70[2-[(2S)-2-(3-Benzoylphenyl)propanoyl]oxy-1-methylpropyl] (2S)-2-(3-Benzoylphenyl)propanoate
Formula:C36H34O6Color and Shape:Neat3-[(2S)-2-(3-Benzoylphenyl)propanoyl]oxybutyl (2S)-2-(3-Benzoylphenyl)propanoate
Formula:C36H34O6Color and Shape:NeatDexketoprofen 1,2-Propylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C19H20O4Color and Shape:NeatBenoxaprofen 1,3-Butylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C20H20ClNO4Color and Shape:Neat(2-Ethoxy-2-oxoethyl) 2-(5-Methoxy-2-methyl-1H-indol-3-yl)acetate
Formula:C16H19NO5Color and Shape:NeatCarprofen 1,2,3-Propanetriol Esters (Mixture of Regio- and Stereoisomers)
Formula:C18H18ClNO4Color and Shape:Neat2-[(2S)-2-(3-Benzoylphenyl)propanoyl]oxypropyl (2S)-2-(3-Benzoylphenyl)propanoate
Formula:C35H32O6Color and Shape:NeatCarprofen 1,2-Propylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C18H18ClNO3Color and Shape:NeatCarprofen 1,3-Butylene Glycol Esters (Mixture of Regio- and Stereoisomers)
Formula:C19H20ClNO3Color and Shape:NeatDiclofenac 2,3-Butylene Glycol Ester
CAS:Controlled ProductFormula:C18H19Cl2NO3Color and Shape:NeatMolecular weight:368.25Aminopyrine
CAS:Controlled ProductFormula:C13H17N3OPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:231.30Roflumilast
CAS:Formula:C17H14Cl2F2N2O3Purity:>98.0%(HPLC)Color and Shape:White to Orange to Green powder to crystalMolecular weight:403.21Dexketoprofen Ethyl Ester
CAS:Controlled ProductFormula:C18H18O3Color and Shape:NeatMolecular weight:282.33Parecoxib
CAS:Formula:C19H18N2O4SPurity:>97.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:370.424-Methylsulfonylacetophenone
CAS:Controlled ProductFormula:C9H10O3SColor and Shape:NeatMolecular weight:198.24Ketoprofen EP Impurity G
CAS:Controlled ProductFormula:C10H9NO2Color and Shape:BeigeMolecular weight:175.18Methyl 2-(3-Benzoylphenyl)propionate (Ketoprofen Methyl Ester)
CAS:Controlled ProductFormula:C17H16O3Color and Shape:White To Light YellowMolecular weight:268.3074-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonyl Chloride (Valdecoxib Sulfonyl Chloride)
CAS:Controlled ProductFormula:C16H12ClNO3SColor and Shape:NeatMolecular weight:333.79Ketoprofen 1,2,3-Propanetriol Esters (Mixture of Regio- and Stereoisomers)
Controlled ProductFormula:C19H20O5Color and Shape:MixtureMolecular weight:656.72Niflumic Acid EP Impurity B
CAS:Controlled ProductFormula:C13H9F3N2O2Color and Shape:NeatMolecular weight:282.22Tinoridine Hydrochloride
CAS:Formula:C17H20N2O2S·HClPurity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:352.88Oxaprozin
CAS:Formula:C18H15NO3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:293.32Sodium Gualenate
CAS:Formula:C15H17NaO3SPurity:>98.0%(HPLC)Color and Shape:Blue to Dark blue powder to crystalineMolecular weight:300.35Fenoprofen Ethyl Ester
CAS:Controlled ProductFormula:C17H18O3Color and Shape:NeatMolecular weight:270.32Suprofen
CAS:Formula:C14H12O3SPurity:>98.0%(GC)Color and Shape:White to Light yellow powder to crystalMolecular weight:260.31Diclofenac Potassium
CAS:Controlled ProductFormula:C14H10Cl2NO2·KColor and Shape:WhiteMolecular weight:334.24(3RS)-1,3-Bis[4-(2-methylpropyl)phenyl]butan-1-one
CAS:Controlled ProductFormula:C24H32OColor and Shape:Colourless To Light YellowMolecular weight:336.51Olsalazine Sodium
CAS:Formula:C14H8N2Na2O6Purity:>98.0%(HPLC)Color and Shape:Light yellow to Brown powder to crystalMolecular weight:346.21Tenoxicam
CAS:Formula:C13H11N3O4S2Purity:>98.0%(HPLC)(N)Color and Shape:White to Yellow to Green powder to crystalMolecular weight:337.37Ketorolac Tromethamine
CAS:Formula:C15H13NO3·C4H11NO3Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:376.41Valdecoxib
CAS:Formula:C16H14N2O3SPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:314.36Nabumetone EP Impurity A
CAS:Controlled ProductFormula:C18H20O2Color and Shape:NeatMolecular weight:268.35Loxoprofen Sodium Salt Dihydrate
CAS:Formula:C15H17NaO3·2H2OPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:304.32Pranoprofen
CAS:Formula:C15H13NO3Purity:>98.0%(GC)(T)Color and Shape:White to Light yellow powder to crystalMolecular weight:255.27(2RS)-2-(3-Benzoylphenyl)propanamide
CAS:Formula:C16H15NO2Color and Shape:NeatMolecular weight:253.302-[(1RS)-8-Ethyl-1-(1-methylethyl)-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Isopropyl Etodolac)
CAS:Controlled ProductFormula:C18H23NO3Color and Shape:NeatMolecular weight:301.38Diclofenac Sodium EP Impurity B
CAS:Controlled ProductFormula:C13H9Cl2NOColor and Shape:YellowMolecular weight:266.122-[(1RS)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic Acid (1-Methyl Etodolac)
CAS:Controlled ProductFormula:C16H19NO3Color and Shape:NeatMolecular weight:273.33Fenclofenac Methyl Ester
CAS:Controlled ProductFormula:C15H12Cl2O3Color and Shape:NeatMolecular weight:311.16Dexibuprofen Methyl Ester
CAS:Controlled ProductFormula:C14H20O2Color and Shape:NeatMolecular weight:220.31Etoricoxib
CAS:Formula:C18H15ClN2O2SPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:358.84N-[(2Z)-3-Ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
CAS:Controlled ProductFormula:C16H17N3O4S2Color and Shape:NeatMolecular weight:379.45Tiaprofenic Acid Methyl Ester
CAS:Controlled ProductFormula:C15H14O3SColor and Shape:NeatMolecular weight:274.33DL-Lysine Acetylsalicylate
CAS:Formula:C9H8O4·C6H14N2O2Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:326.354-(1-Hydroxy-2-methylpropyl)acetophenone
CAS:Controlled ProductFormula:C12H16O2Color and Shape:NeatMolecular weight:192.254Ketoprofen EP Impurity A (Ketoprofen USP Related Compound D)
CAS:Controlled ProductFormula:C15H12O2Color and Shape:NeatMolecular weight:224.25Fenclofenac Ethyl Ester
CAS:Controlled ProductFormula:C16H14Cl2O3Color and Shape:NeatMolecular weight:325.19Fenclofenac Isopropyl Ester
Controlled ProductFormula:C17H16Cl2O3Color and Shape:NeatMolecular weight:339.21Ketoprofen Lysinate
CAS:Controlled ProductFormula:C16H14O3·C6H14N2O2Color and Shape:NeatMolecular weight:400.47Isopropyl 2-(3-Benzoylphenyl)propionate
CAS:Controlled ProductFormula:C19H20O3Color and Shape:NeatMolecular weight:296.36Methyl 2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetate (Methyl Ester of Diclofenac)
CAS:Controlled ProductFormula:C15H13Cl2NO2Color and Shape:NeatMolecular weight:310.18Pimecrolimus
CAS:Formula:C43H68ClNO11Purity:>95.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:810.46Parecoxib Sodium
CAS:Formula:C19H17N2NaO4SPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:392.40Deracoxib
CAS:Formula:C17H14F3N3O3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Brown powder to crystalMolecular weight:397.37(2S)-2-(5-Bromo-6-methoxynaphthalen-2-yl)propanoic Acid (5-Bromonaproxen)
CAS:Controlled ProductFormula:C14H13BrO3Color and Shape:NeatMolecular weight:309.16(3-Benzoylphenyl)ethanenitrile
CAS:Controlled ProductFormula:C15H11NOColor and Shape:Colourless To Light YellowMolecular weight:221.25Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
CAS:Controlled ProductFormula:C12H13NO5SColor and Shape:Off WhiteMolecular weight:283.303-(Trifluoromethyl)aniline
CAS:Controlled ProductFormula:C7H6F3NColor and Shape:NeatMolecular weight:161.12(1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol
CAS:Controlled ProductFormula:C13H14O2Color and Shape:NeatMolecular weight:202.255-Methylthiazol-2-amine
CAS:Controlled ProductFormula:C4H6N2SColor and Shape:NeatMolecular weight:114.17Valdecoxib
CAS:Controlled ProductFormula:C16H14N2O3SColor and Shape:Yellow PowderMolecular weight:314.366-Methoxynaphthalen-2-ol (Hydroxynerolin)
CAS:Controlled ProductFormula:C11H10O2Color and Shape:NeatMolecular weight:174.20Methyl 2-Aminobenzoate (Methyl Anthranilate)
CAS:Controlled ProductFormula:C8H9NO2Color and Shape:NeatMolecular weight:151.162,6-Dichlorodiphenylamine
CAS:Controlled ProductFormula:C12H9Cl2NColor and Shape:NeatMolecular weight:238.11Piroxicam EP Impurity D
CAS:Controlled ProductFormula:C10H9NO5SColor and Shape:NeatMolecular weight:255.25Ethyl 2-(3-Benzoylphenyl)propionate (Ketoprofen Ethyl Ester)
CAS:Controlled ProductFormula:C18H18O3Color and Shape:ColourlessMolecular weight:282.331-Benzyl-1H-indazol-3-ol
CAS:Controlled ProductFormula:C14H12N2OColor and Shape:NeatMolecular weight:224.26Methyl 4-Hydroxy-2-methyl-2H-thieno[2,3-e]1,2-thiazine-3-carboxylate 1,1-Dioxide
CAS:Controlled ProductFormula:C9H9NO5S2Color and Shape:NeatMolecular weight:275.30Butyl 2-(4-Butoxyphenyl)acetate
CAS:Controlled ProductFormula:C16H24O3Color and Shape:NeatMolecular weight:264.36Ethyl (1RS)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (Ketorolac Ethyl Ester)
CAS:Controlled ProductFormula:C17H17NO3Color and Shape:NeatMolecular weight:283.32Flunixin Meglumine EP Impurity B
CAS:Controlled ProductFormula:C8H8F3NColor and Shape:White SolidMolecular weight:175.15Phenylbutazone EP Impurity A
CAS:Controlled ProductFormula:C19H22N2O3Color and Shape:White To Off-WhiteMolecular weight:326.39Diclofenac Sodium EP Impurity C
CAS:Controlled ProductFormula:C13H11Cl2NOColor and Shape:NeatMolecular weight:268.144-Nitro-2-phenoxyaniline
CAS:Controlled ProductFormula:C12H10N2O3Color and Shape:NeatMolecular weight:230.22Piroxicam EP Impurity H
CAS:Controlled ProductFormula:C11H11NO5SColor and Shape:White To Off-WhiteMolecular weight:269.27Ethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate
CAS:Controlled ProductFormula:C11H11NO5SColor and Shape:NeatMolecular weight:269.274'-Methylacetophenone
CAS:Controlled ProductFormula:C9H10OColor and Shape:NeatMolecular weight:134.18Ketorolac EP Impurity H
CAS:Controlled ProductFormula:C16H15NO3Color and Shape:NeatMolecular weight:269.295Methyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
CAS:Controlled ProductFormula:C11H11NO5SColor and Shape:WhiteMolecular weight:269.27Ethyl [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate (Indomethacin Ethyl Ester)
CAS:Controlled ProductFormula:C21H20ClNO4Color and Shape:NeatMolecular weight:385.84Carprofen USP Related Compound A
CAS:Controlled ProductFormula:C12H9NColor and Shape:NeatMolecular weight:167.211-Methylethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
CAS:Controlled ProductFormula:C13H15NO5SColor and Shape:NeatMolecular weight:297.332-Phenoxyaniline
CAS:Controlled ProductFormula:C12H11NOColor and Shape:Off-WhiteMolecular weight:185.221-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one
CAS:Controlled ProductFormula:C14H9Cl2NOColor and Shape:NeatMolecular weight:278.13Ethyl 2-Chloropyridine-3-carboxylate
CAS:Controlled ProductFormula:C8H8ClNO2Color and Shape:NeatMolecular weight:185.611,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin)
CAS:Controlled ProductFormula:C15H10O5Color and Shape:NeatMolecular weight:270.241-Methylethyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
CAS:Controlled ProductFormula:C12H13NO5SColor and Shape:NeatMolecular weight:283.3Methyl 2-(4-Butoxyphenyl)acetate
CAS:Controlled ProductFormula:C13H18O3Color and Shape:NeatMolecular weight:222.28(E)-4-(6-Methoxynaphthalen-2-yl)but-3-en-2-one
CAS:Controlled ProductFormula:C15H14O2Color and Shape:NeatMolecular weight:226.271-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin)
CAS:Controlled ProductFormula:C13H12O2Color and Shape:BeigeMolecular weight:200.233Methyl [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate (Indomethacin Methyl Ester)
CAS:Controlled ProductFormula:C20H18ClNO4Color and Shape:NeatMolecular weight:371.81Etodolac EP Impurity H
CAS:Controlled ProductFormula:C12H15NOColor and Shape:WhiteMolecular weight:189.251-(2,6-Dichlorophenyl)indolin-2,3-dione
CAS:Controlled ProductFormula:C14H7Cl2NO2Color and Shape:NeatMolecular weight:292.12(2RS)-2-(2-Fluorobiphenyl-4-yl)-2-hydroxypropanoic Acid
CAS:Controlled ProductFormula:C15H13FO3Color and Shape:NeatMolecular weight:260.262-(4-Butoxyphenyl)acetic Acid
CAS:Controlled ProductFormula:C12H16O3Color and Shape:NeatMolecular weight:208.25Droxicam
CAS:Controlled Product<p>Applications Droxicam is a non-steroidal anti-inflammatory drug.<br>References Lapeyre-Mestre, M., et. al.: Fundam. Clin. Pharm., 20, 391 (2006)<br></p>Formula:C16H11N3O5SColor and Shape:Off-White To Light YellowMolecular weight:357.344-O-b-D-Glucosyl-5-O-methyllvisamminol
CAS:Controlled Product<p>Applications 4-O-β-D-Glucosyl-5-O-methyllvisamminol is a novel epigenetic suppressor of histone H3 phosphorylation. Potent anti-inflammatory and anti-carcinogenic agent.<br>References Kang, J. et al.: Bioorg. Med. Chem. Lett., 24, 4763 (2014); Kong, X. et al.: J. Ethnopharm., 148, 842 (2013);<br></p>Formula:C22H28O10Color and Shape:NeatMolecular weight:452.456-Hydroxy Etodolac
CAS:Controlled Product<p>Applications 6-Hydroxy Etodolac is an Etodolac (E933100) metabolite.<br>References Humber, L., et al.: J. Med. Chem., 32, 2582 (1989), Koupai-Abyazani, M., et al.: J. Anal. Toxicol., 23, 200 (1999),<br></p>Formula:C17H21NO4Color and Shape:NeatMolecular weight:303.35Celecoxib Carboxylic Acid
CAS:Controlled ProductFormula:C17H12F3N3O4SColor and Shape:Off WhiteMolecular weight:411.363-Hydroxy Loratadine
CAS:Controlled Product<p>Applications An intermediate for the preparation of 3-Hydroxy Desloratadine.<br></p>Formula:C22H23ClN2O3Color and Shape:NeatMolecular weight:398.88Tenofovir Monohydrate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Tenofovir Monohydrate is an HIV-1 RT inhibitor and antiretroviral drug.<br>References Zhao, Z., et al.: Method for preparing medical salts and/or derivatives of tenofovir disoproxil, and their application for preventing and/or treating HBV and HIV/AIDS infections, CN 101574356 (2009);<br></p>Formula:C9H14N5O4P·H2OColor and Shape:NeatMolecular weight:305.23Troglitazone Sulfate Ammonium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Troglitazone Sulfate is the major metabolite of Troglitazone (T892500), a hypoglycemic agent with cholestatic effect.<br>References Ciaraldi, T.P., et al.: Metabolism, 39, 1056 (1990); Kuzuya, T., et al.: Diabetes Res. Clin. Pract., 11, 147 (1991); Kellerer, M., et al.: Diabetes, 43, 447 (1994); Adachi, Y., et al.: Mol. Pharmacol., 67, 923 (2005);<br></p>Formula:C24H30N2O8S2Color and Shape:NeatMolecular weight:538.63Diamino-5-phenylthiazole Hydrobromide
CAS:Controlled Product<p>Applications Diamino-5-phenylthiazole Hydrobromide is an phenylthiazole derivative used in the preparation of antiallergic and antiinflammatory agents.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ban, M. et al.: Bioorg. Med. Chem., 6, 1069 (1998);<br></p>Formula:C9H9N3S·BrHColor and Shape:NeatMolecular weight:272.16Bromfenac Sodium Sesquihydrate
CAS:Controlled Product<p>Applications Bromfenac is a non-steroidal anti-inflammatory agent.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Obach, R., et al.: Drug Metab. Disposition, 36, 1385 (2008), MacDonald, J., et al.: Toxicol. Sci., 110, 40 (2009), Varma, M., et al.: J. Med. Chem., 52, 4844 (2009),<br></p>Formula:C15H11BrNO3·2Na·3H2OColor and Shape:Light YellowMolecular weight:766.349α-Fluoro-11β-hydroxy-16-β-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2’-[4’-chloro-5’-ethylfuran-3’(2’H)-one
CAS:<p>Impurity Clobetasol Propionate EP Impurity J<br>Applications 9α-Fluoro-11β-hydroxy-16-β-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2’-[4’-chloro-5’-ethylfuran-3’(2’H)-one (Clobetasol Propionate EP Impurity J) is an impurity in the synthesis of Clobetasol 17-Propionate (C583500), a topical corticosteroid. Glucocorticoid; anti-inflammatory.<br>References Olsen, E.A., et al.: J. Am. Acad. Dermatol., 15, 246 (1986),<br></p>Formula:C25H30ClFO4Color and Shape:NeatMolecular weight:448.95Benoxaprofen
CAS:Controlled Product<p>Applications A non-steroidal anti-inflammatory ophthalmic agent.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mathur, K., et al.: Bioorg. Med. Chem., 11, 1915 (2003), Zhao, M., et al.: Bioorg. Med. Chem., 15, 2815 (2007), Roy, K., et al.: Eur. J. Med. Chem., 44, 2913 (2009),<br></p>Formula:C16H12ClNO3Color and Shape:NeatMolecular weight:301.72trans-α-Asarone
CAS:Controlled ProductFormula:C12H16O3Color and Shape:White To Off-WhiteMolecular weight:208.25Demethyl Benzydamine Hydrochloride
CAS:Controlled Product<p>Applications A metabolite of Benzydamine (B209950).<br>References Kataoka, S., et al.: Chem. Pharma. Bull., 21, 358 (1973),<br></p>Formula:C18H22ClN3OColor and Shape:Off White SolidMolecular weight:331.84Pranoprofen
CAS:Controlled Product<p>Applications Pranoprofen is an anti-inflammatory used in ophthalmology.<br>References Ayaki, M., et al.: Biocont. Sci., 15, 97 (2010); Lee, X., et al.: For. Toxicol., 28, 96 (2010);<br></p>Formula:C15H13NO3Color and Shape:Off White CrystallineMolecular weight:255.274’-Hydroxy Nimesulide
CAS:Controlled Product<p>Applications The main metabolite of Nimesulide (N477500).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Facino, R.M., et al.: Drugs, 46 (Suppl1),15 (1993), Westphal, J., et al.: J. Antimicrob. Chemother., 33, 387 (1994), Castell, J., et al.: Cell Biol. Toxicol., 13, 331 (1997), Georges, H., et al.: Life Sci., 65, 151 (1999), Singla, A.K., et al.: J. Pharm. Pharmacol., 52, 467 (2000),<br></p>Formula:C13H12N2O6SColor and Shape:White To Light BrownMolecular weight:324.312-(9H-Carbazol-1-yl)acetic Acid
CAS:Controlled ProductFormula:C14H11NO2Color and Shape:NeatMolecular weight:225.243Ketoprofen ethyl ester
CAS:<p>Ketoprofen ethyl ester is a non-steroidal anti-inflammatory drug (NSAID) that is used to reduce inflammation and relieve pain. It is administered orally or by intravenous injection. Ketoprofen ethyl ester has been shown to inhibit the production of lipolytic enzymes in human liver cells, which may be due to its stereoselective inhibition of acyl chain hydrolases. Ketoprofen ethyl ester also inhibits the activity of type strain x-ray diffraction data, which indicates that it can be used as an inhibitor of hydrogen bond formation. The effective dose for ketoprofen ethyl ester is not yet known, but toxicity studies show that it does not cause any significant adverse effects on the central nervous system or other organs in rats at doses up to 2g/kg.</p>Formula:C18H18O3Purity:Min. 95%Color and Shape:Colorless Clear LiquidMolecular weight:282.33 g/molApomorphine
CAS:Controlled Product<p>Apomorphine is a chemical compound that can be used as an analytical tool to study the effects of dopamine on physiological processes, and pharmacological agents on pharmacokinetics. It is also used in the treatment of Parkinson's disease. Apomorphine is a potent agonist at dopaminergic receptors in the central nervous system, and has been shown to increase locomotor activity and improve the rotarod test performance in rats. Apomorphine binds to dopamine receptors in the brain, replacing dopamine as it becomes depleted. The drug also blocks reuptake of dopamine by neurons and increases release of dopamine from nerve terminals. Apomorphine has a short half-life of about 2 hours, but may have potential for long-term treatment because its effects can last up to 24 hours.</p>Formula:C17H17NO2Purity:Min. 95%Color and Shape:PowderMolecular weight:267.32 g/mol(R)-(-)-Ibuprofen
CAS:<p>Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and inflammation. It belongs to the group of fatty acid derivatives, which are drugs that block the production of prostaglandins. Ibuprofen has been shown to have contraceptive effects in humans and experimental models, as well as an effect on human serum lipoproteins. Ibuprofen has also been shown to inhibit the synthesis of prostaglandins in rat liver microsomes and asymmetric synthesis in wastewater treatment. Its pharmacokinetic properties are determined by its absorption rate, distribution volume, and metabolism rate. The kinetic behavior of ibuprofen is affected by matrix effect and the kinetic behavior of ibuprofen is also affected by its pharmacokinetic properties such as isooctane, carcinoma cell lines, etc.</p>Formula:C13H18O2Purity:Min. 95%Color and Shape:White PowderMolecular weight:206.28 g/molIbuprofen
CAS:<p>Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain, fever and inflammation. Ibuprofen is an inhibitor of cyclooxygenase 1 (COX-1), which blocks the production of prostaglandins that cause pain and inflammation. Ibuprofen has been shown to inhibit the growth of bacteria in cell culture by inhibiting protein synthesis. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. Ibuprofen has been shown to inhibit the production of tumour necrosis factor-α (TNF-α) and serum enzymes, such as dismutase activity, in mice with lung cancer.</p>Formula:C13H18O2Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:206.28 g/molNaloxone hydrochloride
CAS:Controlled Product<p>Naloxone hydrochloride is a competitive antagonist at mu-, delta- and kappa-opioid receptors. Naloxone binding to receptors blocks the effects of opioids such as morphine, heroin, or oxycodone. Naloxone has been shown to be effective in treating acute overdoses of these drugs and reversing the depression of respiratory function that accompanies opioid overdose. It is also used to alleviate withdrawal symptoms and in the treatment of neonatal abstinence syndrome (NAS). NAS is a condition that occurs when infants are exposed to addictive levels of opioids in utero and go through withdrawal after birth.</p>Formula:C19H21NO4•HClPurity:(%) Min. 95%Color and Shape:PowderMolecular weight:363.84 g/molAcrivastine
CAS:<p>Acrivastine is a drug that belongs to the group of combination therapy. It is used in the treatment of autoimmune diseases, such as choroidal neovascularization. Acrivastine inhibits the production of prostaglandin E2 (PGE2) and inhibits the release of histamine from mast cells. Acrivastine also has immunosuppressive effects. It binds to H1 receptors and blocks their activation by histamine, which may be responsible for its therapeutic effect on eye disorders and infectious diseases. Acrivastine is chemically stable in acidic or alkaline conditions, but does not dissolve in organic solvents.</p>Formula:C22H24N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:348.44 g/mol(R)-Apomorphine hydrochloride hemihydrate
CAS:<p>Apomorphine hydrochloride is the salt form of apomorphine, a morphine derivative D2 dopamine agonist. The high selectivity for D2, D3, D4 and D5 receptors makes apomorphine hydrochloride a possible drug candidate and it is in clinical trials for diagnosis and treatment of Parkinsons disease. Moreover, apomorphine and apomorphine hydrochloride have been investigated in diverse studies for treating movement disorders.</p>Formula:C17H17NO2•HCl•(H2O)0Purity:Min. 95%Color and Shape:White PowderMolecular weight:312.79 g/molDextromethorphan
CAS:Controlled Product<p>9-alpha,-14-alpha-3-Methoxy-17-methylmorphinan (914) is a drug that is used in the treatment of bowel disease. It has been shown to inhibit the activity of enzymes such as polymerase chain, which is responsible for DNA replication and repair. 914 also inhibits dextromethorphan, an opioid that is used in cough suppressant medications. The effects of 914 on dextromethorphan are seen in human subjects who have been given the drug intravenously or orally. 914 binds to receptors that are found on cells in the brain and spinal cord, which explains its analgesic properties. This drug can be dangerous when taken with nonsteroidal anti-inflammatory drugs because it can cause kidney damage or failure.</p>Formula:C18H25NOPurity:Min. 95%Color and Shape:PowderMolecular weight:271.4 g/molLopinavir metabolite M-1
CAS:<p>Lopinavir M-1 is a metabolite of lopinavir, which is an HIV protease inhibitor. Lopinavir M-1 has been shown to have antiviral activity against HIV-1 and other retroviruses. It is a versatile building block that can be used as a reagent or a complex compound in the synthesis of other compounds. Lopinavir M-1 also has antiviral activity against HIV-2 and SIV, but not against the influenza virus.</p>Formula:C37H46N4O6Purity:Min. 95%Molecular weight:642.78 g/molKetoprofen
CAS:<p>Inhibits cyclooxygenase-1 and -2; non-steroidal anti-inflammatory drug</p>Formula:C16H14O3Purity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:254.28 g/molDarunavir Ethanolate
CAS:<p>Darunavir is a HIV-1 protease inhibitor used orally in the treatment of patients with multi-drug resistant HIV-1 infection (Ghosh, 2007). It has also been shown to be effective against other infectious diseases such as hepatitis C virus and SARS coronavirus. Metabolized by cytochrome P450 3A (CYP3A) isoenzymes, darunavir is often administered together with ritonavir that prolongs its bioavaiability, giving a terminal elimination half-life (t1/2) of 15 hours (Back, 2008). The effect of darunavir on natural compounds such as matrix proteins and toll-like receptor activity has also been studied via high performance liquid chromatography (HPLC) experiments.</p>Formula:C27H37N3O7S·C2H6OPurity:Min. 95%Color and Shape:White PowderMolecular weight:593.73 g/molLoxoprofen sodium
CAS:<p>Inhibitor of prostaglandin production; non-steroidal COX inhibitor</p>Formula:C15H17NaO3Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:268.28 g/molRivaroxaban
CAS:<p>Rivaroxaban is a natural drug that is a direct factor Xa inhibitor. It has been shown to be an effective therapy for the treatment of atrial fibrillation, deep vein thrombosis (DVT) and pulmonary embolism (PE). It works by inhibiting the enzyme, thrombin, which is responsible for the formation of blood clots. Rivaroxaban also has an effect on the coagulation system by decreasing the levels of fibrinogen and increases in antithrombin III. This drug does not have any specific antidote, but it can be reversed with heparin. Pharmacodynamics and drug interactions have been studied extensively in preclinical models, demonstrated by the concentration–time curves.</p>Formula:C19H18ClN3O5SPurity:Min. 98 Area-%Color and Shape:White Off-White PowderMolecular weight:435.88 g/molSaquinavir mesylate
CAS:<p>Anti-viral; HIV protease inhibitor</p>Formula:C38H50N6O5•CH4O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:766.95 g/molRivastigmine N-Oxide
CAS:<p>Please enquire for more information about Rivastigmine N-Oxide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C14H22N2O3Color and Shape:PowderMolecular weight:266.34 g/molRivastigmine tartrate
CAS:Controlled Product<p>Acetylcholinesterase and butyrylcholinesterase inhibitor</p>Formula:C18H28N2O8Purity:Min. 95%Color and Shape:White PowderMolecular weight:400.42 g/mol




